Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06773000 · ClinicalTrials.gov registry record · NA
Nutritional Supplementation in Geriatric Hip Fractures
A NA study of Geriatric Hip Fracture, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT06773000: Recruiting NA study of Geriatric Hip Fracture, sponsored by NYU Langone Health.
NCT06773000 is a NA study of Geriatric Hip Fracture that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 118 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06773000, a NA study of Geriatric Hip Fracture, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized controlled trial comparing outcomes between geriatric hip fractures who received a commercially available (XR RecoveryTM, Salt Lake City Utah) peri-operative nutritional supplement for three weeks post-operatively to those who receive standard nutritional counseling. The main question it aims to answer is: \- Does supplementation decrease muscle loss via ultrasound measurements of the cross-sectional area of the rectus femoris of the uninjured leg?
Primary Outcome
Outcome measure will be measured using ultrasound imaging.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT XR™ Recovery Supplement
- DIETARY_SUPPLEMENT XR Carbohydrate Loading Supplement
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-01-16 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT06773000 shows while recruiting
NCT06773000 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Geriatric Hip Fracture appearing as the primary indexed condition, and to 2 interventions - of which XR™ Recovery Supplement is the first listed.
NCT06773000 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06773000 about?
NCT06773000 is a clinical study titled "Nutritional Supplementation in Geriatric Hip Fractures". This study is a randomized controlled trial comparing outcomes between geriatric hip fractures who received a commercially available (XR RecoveryTM, Salt Lake City Utah) peri-operative nutritional supplement for three weeks post-operatively to those who receive standard nutritional counseling. The m...
What is the current status of trial NCT06773000?
This trial is currently recruiting. It is a NA study. The enrollment target is 118 participants. The study started on 2025-01-16. Estimated completion is 2027-06-30.
What conditions does trial NCT06773000 study?
This clinical trial studies the following conditions: Geriatric Hip Fracture.
What interventions are being tested in trial NCT06773000?
The interventions under investigation include: XR™ Recovery Supplement (DIETARY_SUPPLEMENT), XR Carbohydrate Loading Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06773000?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06773000 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06773000's enrollment target sits among peer trials
118 803rd of 2000 higher than 1,195 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI